어라이브 AI(ARAI) 2026년 2분기 실적 발표 컨퍼런스 콜: AP3 플러스 본격화 및 상업적 파이프라인
어라이브 AI는 2026년 2분기 매출이 1만 4,700달러로 1분기와 유사했다고 발표했습니다. 일회성 컨설팅 프로젝트를 제외하면 전년 동기 대비 소폭 증가했습니다. 순손실은 사채 전환 관련 비현금성 비용을 포함해 1,410만 달러로 확대되었으며, 비GAAP 순손실은 430만 달러를 기록했습니다. 6월 말 기준 현금 및 유동성 자산은 510만 달러이며, 월간 현금 소진액은 약 110만 달러입니다. 경영진은 9월 중순까지 AP3 플러스 재고를 확보하고, 2027년 1분기 AP4 출시를 목표로 하고 있습니다. 상업적 활동은 초기 논의 및 의향서 단계에 머물러 있으며, 자금 조달 방안을 검토 중입니다.
핵심 요약
- 어라이브 AI(Arrive AI)는 2026년 2분기 매출이 1만 4,700달러로 1분기와 거의 변동이 없었다고 발표했습니다. 2025년 2분기의 일회성 컨설팅 프로젝트를 제외하면 매출은 전년 동기 대비 소폭 증가했습니다.
- 보고된 순손실은 미상환 사채 전환 관련 비현금성 비용 970만 달러를 포함해 전년 동기의 370만 달러에서 1,410만 달러로 확대되었습니다. 해당 비용을 제외한 비GAAP(Non-GAAP) 순손실은 430만 달러였습니다.
- 2026년 6월 30일 기준 현금 및 유동성 투자 자산은 총 510만 달러로, 2025년 12월 31일 기준 현금 210만 달러와 비교됩니다. 회사의 현재 월간 현금 소진액은 약 110만 달러입니다.
- 경영진은 9월 중순까지 12대 이상의 AP3 플러스 어라이브 포인트(AP3 Plus Arrive Points) 재고를 확보해 출고 준비를 마칠 것으로 예상하고 있습니다. 차세대 모델인 AP4는 여전히 2027년 1분기를 목표로 하고 있습니다.
- 상업적 활동은 헬스케어, 제약 제조 및 전문 의약품 배송 분야에 집중되어 있습니다. 다만 여러 사업 기회는 여전히 의향서(LOI) 체결, 파일럿 논의 또는 초기 협상 단계에 머물러 있습니다.
- 어라이브 AI는 8월 17일 자로 피유시 파드케(Piyush Phadke)를 CFO로 선임했습니다. 경영진은 자금 조달 방안을 검토하는 과정에서 그의 자본시장 및 상장기업 재무 경험을 강조했습니다.
주요 재무 데이터
| 지표 | 2026년 2분기 | 비교 및 설명 |
|---|---|---|
| 매출 | 1만 4,700달러 | 1분기 수준 유지, 2025년 2분기 일회성 컨설팅 프로젝트 제외 시 전년 동기 대비 소폭 증가 |
| 보고된 순손실 | 1,410만 달러 | 2025년 2분기 370만 달러와 비교 |
| 비현금성 사채 전환 비용 | 970만 달러 | 보고된 순손실에 포함됨 |
| 비GAAP 순손실 | 430만 달러 | 사채 전환 비용 제외 |
| 현금 및 유동성 투자 자산 | 510만 달러 | 2026년 6월 30일 기준; 2025년 12월 31일 기준 현금 210만 달러와 비교 |
| 현재 현금 소진액 | 월 약 110만 달러 | 인력, 기술 및 인프라 투자 반영 |
| ATM(장내주식매각) 한도 | 최대 약 1,500만 달러 | 매각 시기 및 금액은 분기별로 보고될 예정 |
| 2025년 지분 라인 한도 | 1,900만 달러 | 향후 선급 선지급금을 통해 이용 가능 |
| S-3 증권신고서 | 최대 1억 달러 | 해당 분기 중 제출됨 |
사업 및 영업 성과
어라이브 AI는 제한적인 도입 단계에서 초기 재고 구축 단계로 이동하고 있습니다. 9월 중순까지 12대 이상의 AP3 플러스 제품을 사용할 수 있을 것으로 예상됩니다. 이 제품에는 고객이 어라이브 포인트 및 광범위한 네트워크를 모니터링할 수 있는 새로운 운영체제와 소프트웨어가 포함되어 있습니다.
헬스케어는 회사의 가장 안정적인 도입 분야로 남아 있습니다. 한콕 리저널 병원(Hancock Regional Hospital)은 해당 분기 동안 어라이브 포인트를 추가로 도입해 건물 간 이동을 가능하게 했습니다. 경영진은 구체적인 금액을 밝히지 않았으나, 이러한 확장이 2026년 3분기 및 4분기에 추가 매출을 창출할 것으로 기대하고 있습니다.
또한 어라이브 AI는 넥서스 AMR(Nexus AMR)과 파트너십을 체결했으며, 넥서스 AMR은 자사의 자동화 포트폴리오에 어라이브 AI의 제품을 포함하고 텍넥서스 혁신센터(TECNEXUS Innovation Center)에서 해당 기술을 선보일 예정입니다. 경영진은 이 협력 관계가 병원, 의료 및 제약 고객 전반에서 추가적인 잠재 고객(리드)을 창출하고 있다고 밝혔습니다.
제조 분야에서 어라이브 AI는 DXC와 협력하여 대형 제약 제조 시설에 자사 기술을 도입하고 있습니다. 경영진은 DXC의 시스템 통합(SI) 역량이 대기업 고객과 보다 효율적으로 연결되는 데 도움이 될 수 있다고 언급했습니다.
회사는 라이프스팬 파마시(LifeSpan Pharmacy) 및 카돈(CarDon)과 자율주행 드론 의약품 배송 프로그램을 모색하기 위한 의향서(LOI)를 체결했습니다. 또한 몇몇 포춘 500대 기업들과 잠재적인 의약품 배송 기회에 대해 초기 단계의 논의를 진행하고 있습니다.
어라이브 AI는 별도로 무인 배송을 위한 어라이브 포인트 활용 파일럿 가능성에 대해 에이브라이드(Avride)와 초기 논의를 진행 중입니다. 에이브라이드는 연말까지 미국 내 20개 이상의 캠퍼스에서 운행할 계획이지만, 경영진은 이들 캠퍼스가 확정된 어라이브 포인트 도입을 의미하는 것은 아니라고 설명했습니다.
회사는 미국에서 등록된 특허 10건과 출원 중인 특허 4건이 있다고 발표했습니다. 또한 주로 아시아 지역에 13건의 등록된 해외 특허를 보유하고 있으며, 최근 첫 번째 유럽연합(EU) 특허 승인을 받았습니다. 경영진은 해외 라이선싱 기회를 검토 중이라고 밝혔습니다.
경영진 전망
경영진은 2026년 9월 중순까지 12대 이상의 AP3 플러스 제품이 재고로 확보되어 출고 준비가 완료될 것으로 예상합니다.
AP4는 2027년 1분기를 목표로 하고 있습니다. 이 제품은 다중 배송, 자율이동로봇(AMR)의 동시 픽업 및 하차, 드론 배송을 지원하도록 설계되고 있습니다. 공급망은 2027년 중 수백 대 규모로 확대하는 것을 목표로 하고 있으나, 경영진은 해당 수준의 실제 도입 여부는 여전히 불확실하다고 주의를 당부했습니다.
어라이브 AI는 또한 AP5라고도 불리는 APX 시제품을 2027년 말까지 확보할 것으로 예상하고 있습니다. 관련 공급망은 향후 수천 대에서 수만 대 규모의 생산을 목표로 설계되고 있지만, 이는 도입 확약이라기보다는 장기적인 개발 목표에 가깝습니다.
리스크 및 주요 관전 포인트
- 매출은 보고된 손실 금액 및 월 약 110만 달러의 현금 소진액에 비해 여전히 제한적인 수준입니다.
- 향후 자금 조달에는 회사의 ATM 프로그램, S-3 증권신고서 또는 남은 지분 라인 한도가 활용될 수 있습니다. 경영진은 자금 조달 옵션을 보유하고 있으며, 재무제표와 장기적인 주주 이익에 초점을 맞춰 이를 관리하고 있다고 밝혔습니다.
- 여러 상업적 기회가 여전히 초기 단계 논의에 머물러 있거나 의향서(LOI) 체결 수준에 그치고 있습니다. 경영진은 계약이 체결된 후에만 확정된 건으로 간주할 것이라고 말했습니다.
- 공급망은 훨씬 더 높은 생산 규모에 맞춰 설계되고 있으나, 경영진은 2027년에 AP4 수백 대를 도입하는 것이 보장되지는 않는다고 인정했습니다.
- 투자자 질문에서는 주가, 나스닥 상장 유지 요건 준수, 상장폐지 가능성 및 유동성에 대한 우려가 제기되었습니다. 경영진은 상업적 문의, 제품 개발 및 자금 조달의 유연성을 강조하며 답변했습니다.
애널리스트 Q&A 주요 내용
어라이브 포인트 수십 대에서 수백, 수천 대로 확장하는 과정에 대한 질문에, 경영진은 이러한 확장이 조율된 제품 및 공급망 개발에 달려 있다고 답변했습니다. AP3 플러스는 새 플랫폼의 첫 번째 단계이며, AP4는 수백 대를 지원할 수 있는 공급망에 맞춰 설계되었고, APX/AP5는 훨씬 더 큰 규모를 염두에 두고 있습니다.
경영진은 에이브라이드(Avride)가 20개 이상의 캠퍼스에 진출할 예정이라는 점이 어라이브 포인트 20대의 추가 주문으로 이어지는 것은 아니라고 분명히 했습니다. 양사는 현재 잠재적인 파일럿 프로그램에 대해 논의 중입니다.
상업적 전환과 관련하여 경영진은 파트너 논의 중 의미 있는 일부가 2차 및 3차 대화 단계로 진행되었다고 밝혔습니다. 회사는 향후 12개월 동안 가장 뛰어난 전략적 적합성을 제공하는 도입을 우선시하고 있습니다.
마케팅과 관련해 어라이브 AI는 자사의 전략이 광범위한 소비자 대상 광고보다는 타깃형 기업 접근 방식이라고 설명했습니다. 안전한 관리 연속성(chain of custody), 무인 배송, 그리고 드론 및 로봇 플릿 간 통합의 혜택을 누릴 수 있는 조직에 초점을 맞추고 있습니다.
실적 발표 전화회의 전문
전체 실적 발표 컨퍼런스 콜 녹취록
경영진 발표
Operator
Good morning, everyone, and thank you for joining us today. On the call is Dan O'Toole, Arrive AI's Chairman, CEO, and Founder, along with Ian Geise, our Head of Commercialization, who's joining us for the first time today. The rest of Arrive AI's leadership team is also here to answer questions later in the call. The earnings press release issued this morning is available in the Investor Relations section of the company's website at arriveai.com.
Before we begin, please note that today's remarks may include forward-looking statements regarding future financial results, operations, and performance. These statements are not guarantees of future results and are subject to risk and uncertainties that could cause actual outcomes to differ materially. We encourage investors to review the Risk Factors section detailed in Arrive AI's SEC filings, which are also available on the company's website.
Now, I will turn the call over to Arrive AI's CEO, Dan O'Toole.
Daniel O’Toole
Thank you. Hey everyone, Dan O'Toole here. Thank you for joining us today. We're going to keep our prepared comments concise, so let's get right to it. But I also want to say, why don't you ever see elephants hiding in trees? Because they've gotten really good at it. But I really want to say the elephant in the room has arrived with AI. We're seeing a huge uptick in big players wanting to explore deploying our technology, and that is what is really exciting. So let's get this going.
To start this morning, I'd like to welcome Piyush Phadke as Arrive AI's new CFO, Chief Financial Officer, effective August 17th. As detailed in this morning's press release, Piyush brings more than two decades of Wall Street experience, including senior capital markets roles at Bank of America, BTIG, and Jefferies before moving into public company CFO leadership. That combination gives him a rare vantage point. He sat on the banking side, structuring financing for growth companies, and he sat in the CFO seat, managing the balance sheet and investor relationships that come with public company life.
What stood out to me most is how aligned Piyush is with our vision for Arrive AI. He understands the scale of the opportunity in front of us in autonomous logistics. And he's just as focused as we are on translating this quarter's commercial traction into long-term shareholder value, which I will elaborate on shortly. We'll hear directly from him on future calls and in the investor conversations as we move forward. I also want to thank Todd Pepmeier for his contributions while here at Arrive AI.
Now let's get into what's driving the business forward, including real commercial traction, continued technology progress and a clear opportunity ahead for Arrive AI. The prepared remarks you're about to hear will be delivered using AI-generated versions of both mine and our Head of Commercialization's voice, Ian Geise. That's the same format that we've used in the past. For us, this reflects how we think about artificial intelligence as a practical tool that can improve efficiency, scalability, and communication, the same philosophy that drives our platform and autonomous logistics network.
After the prepared remarks conclude, we'll return to a live question-and-answer session on questions that were submitted ahead of this call. So with that said, let's begin the prepared remarks.
Thanks, everyone. This quarter, we want to spend less time talking about where we're headed in the abstract and more time talking about the deals and partnerships and the progression we have made over the past several months. We expect to have more than a dozen AP3 Plus Arrive Points in stock and ready to ship by mid-September, representing our first wave of expanded availability and the solidification of our supply chain. Looking ahead, we're already developing the AP4, which is targeted for the first quarter of 2027 and will build on what AP3 Plus brings to the network. This is ideal timing to take advantage of the commercial traction we are seeing in the second half of the year.
To walk through that in detail, I've asked Ian Geise, our Head of Commercialization, to join us today for the first time. Ian leads our commercial pipeline, and he's going to provide you with an inside look at where things stand.
Ian Geise
Thanks, Dan. It's easiest to think about our pipeline across three industries where we're seeing the strongest traction right now: healthcare, manufacturing and specialty pharmacy delivery. In healthcare, Nexus AMR is pleased to partner with us to deliver end-to-end autonomous solutions for customers across multiple industries. The integration of Arrive AI's products into their automation portfolio enhances productivity and expands the value they deliver to healthcare organizations and other businesses facing persistent and growing labor challenges. Customers from around the world regularly visit the TECNEXUS Innovation Center, where they showcase best-in-class autonomous mobile robots and emerging technologies. Nexus is proud to feature Arrive AI's innovative solutions and has welcomed us as a key strategic partner.
Hancock Regional Hospital remains our anchor healthcare deployment. And this quarter, Hancock expanded their network by adding an additional Arrive Point, enabling building-to-building movement. This is a significant milestone since demand for building-to-building movement and secure exchange will be paramount in healthcare and in large campus facilities.
In manufacturing, we've partnered with DXC to bring our technology into large pharmaceutical manufacturing environments, facilities with a global footprint, each spanning 500,000 square feet or more where moving product across the campus, including by drone for longer distances, is a real operational need. DXC's systems integration expertise also helps us plug into large enterprise customers faster than we could on our own.
We've also announced a letter of intent with LifeSpan Pharmacy and CarDon to explore an autonomous drone pharmacy delivery program. We are also engaged in early-stage discussions with several Fortune 500 companies regarding potential pharmaceutical delivery opportunities.
We're also seeing broader momentum with our autonomous delivery partners. Avride, which builds autonomous delivery robots backed by one of the industry's longest-running autonomous driving programs, became the continuity partner for universities when Starship Technologies exited U.S. campus operations. By the end of this year, Avride expects to be operating on more than 20 campuses nationwide, working with Grubhub, Uber Eats and major food service operators.
What's next for Avride is more campuses, expanded city deployments, faster and more reliable service, and most importantly, where we fit in, creating partnerships across the ordering and logistics stack so last-mile delivery becomes truly autonomous, end to end. This mutual goal will be key as we identify potential partners. As of today, we have a growing number of commercialization conversations underway, and a meaningful subset of those have already progressed into second- and third-round discussions. These later-stage conversations are with partners we believe are the most likely to move forward into formal agreements.
We're introducing this framing to give you a clearer view into the momentum we're seeing and our traction with potential partners. At the same time, we'll continue to only treat agreements as firm once they're signed, and we'll announce each finalized partnership individually as it's secured. We expect to keep building on this across healthcare, manufacturing and specialty delivery in the coming quarters.
Daniel O’Toole
Thanks, Ian. On the financial side, given the very recent CFO transition, I will walk through the highlights for the second quarter results. Second quarter revenue was in line with Q1 at $14,700 for the quarter. Our recently announced expansion with Hancock is expected to produce incremental revenue in the third and fourth quarters this year.
Excluding revenue from a non-recurring consulting project in the year-ago quarter, revenue was up slightly year over year. Net loss for the second quarter was $14.1 million compared to the $3.7 million net loss in the second quarter of 2025. However, the reported net loss includes $9.7 million in non-cash expenses related to the conversion of our outstanding notes. Excluding these non-cash expenses on a non-GAAP basis, net loss for the second quarter was $4.3 million. Cash and liquid investments on hand were $5.1 million at June 30th, an increase from $2.1 million in cash at December 31st. Our current cash burn rate is approximately $1.1 million per month.
During the quarter, we completed the filing of an S-3 registration statement for up to $100 million. We also finalized the terms of our at-the-market offering, or ATM offering, up to a maximum capacity of approximately $15 million. The amount and timing of sales under that agreement will be disclosed quarterly as required. In addition, we retain the available capacity of $19 million in future prepaid advances under our previous 2025 equity line facility.
I also want to speak directly to something I know is on a lot of people's minds, our ability to keep funding this business going forward. We continue to have real optionality in front of us right now on financing, and Piyush's capital markets background is already helping us sharpen how we think about those paths. Our current cash burn reflects deliberate investment in the team, technology, and infrastructure required to convert our commercial pipeline into scaled revenue. And we're being careful about which financing and operating decisions we make and when to do what's right for shareholders over the long term. At the same time, we are prudently managing operating and investment spend to drive growth while maintaining a disciplined focus on the balance sheet.
I want to be direct about this. We are not in a position where we're at risk of running out of funds. We have options, and with Piyush's experience structuring financing for growth companies, we're working through them strategically and with real discipline.
To wrap up, this quarter is about proof: real partnerships, real deployments and real momentum in our pipeline across healthcare, manufacturing and specialty delivery. We appreciate your continued support and engagement.
With that, Ian and I will now return live for Q&A, along with the rest of our team.
Operator
[Operator Instructions] And our first question comes from Jack Codera with Maxim Group.
질의응답
Jack Codera
You guys highlighted a couple of partnerships. And then you mentioned there, about a dozen Arrive Points kind of targeted to be ready to ship this, I think you said by the end of this year. I'm wondering how many Arrive Points do you have out there operating right now? And kind of how does that connect to, like for example, this like 20 campuses you're taking over? Is that like an incremental 20 Arrive Points? How should we be thinking about that?
Daniel O’Toole
Yes, hey, real quick. Thanks for being on the call here, Jack. Dan O'Toole, CEO. I just want to say that the over a dozen units that we mentioned in the earnings call represents a huge multiplier of our past deployments. So while over a dozen isn't a huge number in the abstract, it really marks on our traction that we're seeing, and it's a huge multiplier on what we've had deployed so far. So I think the trajectory is really vertical for where we're going and what we're doing. I'm going to let Ian Geise, our Head of Commercialization, take the last part of that question. Go ahead, Ian.
Ian Geise
Yes, just to clarify the statement on campuses, the news that was iterated in that statement had to do with Avride's takeover of Starship's departure from campuses to do on-campus delivery. We are in early conversations with Avride right now of employing the Arrive Point network into potential pilot programs in which we could increase efficiencies for unattended delivery.
Jack Codera
Okay, yes, that's perfect clarification. And it's exciting to see that you're getting a multiplier on kind of what was existing out there. I guess, kind of the big question is, how should we think about -- what are the big sticking points that you're kind of seeing that will enable you to start talking about Arrive Points in -- kind of like hundreds of Arrive Points or thousands of Arrive Points? Do you think it's -- is it more about adoption? Do you need more manufacturing scope? I'd just like to get your thoughts like on the main sticking points.
Daniel O’Toole
Thanks, Jack. We appreciate the thoughtful questions and the opportunity to share these answers that I'm sure a lot of people are thinking about. I'm going to ask Mark Hamm, our COO, to take that one. Mark?
Mark Hamm
Yes, thanks, Jack, for the question. In Q1, we consolidated our roadmap, our product plan, our supply chain and the delivery of the 12 units in September. That's the first installment on new units -- it's called AP3 Plus -- that have our new operating system and our new software that enables operators and customers to see everything that's going on with their Arrive Points and their network.
Then what comes in Q1 is AP4, which is the first product that will support multiple deliveries at once, AMR pickup and drop off at the same time, drone delivery. And that supply chain has been designed to scale to hundreds over the course of 2027. It remains to be seen if we deploy that many, but that's what we're looking at supply chain-wise.
And then the following year, we would have prototypes at the end of next year for APX, the future generation, or AP5, you may hear it called, which is designed for even greater capacity and more automated handoffs in more situations. And that supply chain is being designed for thousands, tens of thousands. So it's a progression, a ramp. And kind of in parallel, once the supply chains are in place for that, then go-to-market follows that and provides the opportunities.
Operator
Thank you. I would now like to turn the call back over to Arrive AI for questions.
Daniel O’Toole
Yes, real quick. All right. This is Dan. I'm going to take this opportunity to introduce Piyush Phadke, our new CFO. Piyush, thanks for joining the call and thanks for joining the company. I'm really excited.
I just -- I want to give a quick shout-out, I guess, to Adele with Alliance Advisors, our trusted partner, our investor relations firm. They knew we were looking to get a really like-minded, educated or streetwise, I guess you could say, CFO. Somebody that -- my personal wish list was somebody that was entrepreneurial, somebody that could navigate the capital markets, could narrate an earnings report to analysts and investors and be M&A-minded. And I think we've got exactly what we're looking for. Piyush, if you're there, I'd like to say hey to you and have you give a little bit of a background on yourself to our investors.
Piyush Phadke
Sure. Thank you. Thank you, Dan. And thank you to the team and to investors who have joined this call. So I'm Piyush Phadke, I'm the new CFO of Arrive AI. I am very excited to be here. I really believe in the mission and believe we are the future of autonomous deliveries.
You know, for me, joining was all about fit. I came to the office near Indianapolis last week and spent time, spent three days there with everyone, up from Dan to all the C-suite, the developers, engineers. And the thing that I noticed was just really the energy that, you know, that flows from Dan. But really, everyone was just so excited to be there and to be able to be building something that's going to be big.
And I was able to see kind of a demo of an Arrive Point, and I had never seen it before other than kind of on the website. And it was really interesting to kind of see that live and see how the different technology works. So I'm really excited for the opportunity, and I'm looking forward to doing a lot of great things with Dan and team.
Daniel O’Toole
Thanks so much, man. We're looking forward to really leveraging your relationships and getting our sleeves rolled up and getting us to the next level. So really excited that you're on our team, man. I can't wait to hit the ground running here.
I want to turn this over to Tasha Jones, our Head of Marketing. And she's going to tee us some questions up there. Tasha?
Tasha Jones
Yes. The first question we have here, we received several questions about the stock price and the NASDAQ compliance, including concerns about a potential delisting or liquidity issues. This comes from Leon, Jake, Robert and [ Brenski ].
Daniel O’Toole
I'm going to -- the way we're going to format this, I'm going to assign questions so we're not tripping over each other. I'll assign answers. I'm going to take this one myself. Dan O'Toole, CEO.
Obviously, the big thing every day is share price traction, delisting and all these kind of things. Yes, I can tell you this. We went public over a year ago, 5,000 pre-public investors on our cap table. We have everyone shoulder to shoulder with us when we think about share price, market traction, having a great product. There's a whole formula of specifics that come together that equal your share price, your market cap and how you're viewing the market.
And I can tell you, when we went public a year ago, it was never in the plan to be profitable day one. It was never in the plan to be revenue neutral day one. What wasn't the plan was to lose money. And that wasn't because we wanted to lose money. It's just the reality. When you're running in a race, you don't start at the fastest speed, you start from a standing stop and you get faster and faster.
Well, I can tell you, we are getting faster and faster. The amount of inbound inquiries that are coming into our company are bigger than we've ever seen. In the last 30 days, we've had more inquiries than we've had in the history of the company put together. The market is taking note of what we're doing and then realizing that autonomous delivery and pickup of all sorts will not happen without an Arrive Point in that ecosystem.
We unlock autonomy. We're creating a frictionless environment between drones, robots, APs and people, and that is what the market needs. Scalability, when you're dropping things on the ground or picking them up from the ground, is a non-starter. When you add unattended delivery from Arrive AI, it all changes.
And when you guys invest into this company, you invest in our IP. Our IP starts where autonomous delivery and pickup starts. So if you have a locker or a mailbox, that's fine. That's public domain, that's old. When you have this new element of autonomous delivery and pickup where everything is going, that is Arrive AI. We are building that infrastructure. We own the doorstep to every public business throughout the world. So that's where you're investing in. Tash, I'm going to hand it to you.
Tasha Jones
Yes, so we also received a couple of questions asking us to describe our growth plan for the remainder of this year and next, including how we plan to scale revenue and secure purchase orders, letters of intent and strategic partner agreements. This was Raul and Albert's question.
Daniel O’Toole
I'm going to hand it over to Ian. Ian is our Head of Commercialization. Go ahead, Ian.
Ian Geise
Thank you for the question. I think we addressed most of that in my prepared statement, but I'll go ahead and answer it, especially off the great words that Dan just stated. And that is the amount of awareness that is now for the inefficiencies of drop-off, pickup throughout all of the different companies that have been launched, whether it's drone companies or robotics companies, there's more and more awareness for what is lacking, and that is indeed the Arrive Point of being able to do the handoff and the pickup.
Nexus saw this clearly, and we created that partnership with Nexus and we're getting more and more leads that are coming in the pipeline for hospital systems, medical, pharmaceutical, and they keep growing exponentially. So we anticipate very big things from all of these different elements of our pipeline. And as Mark stated in terms of the product deployments, we are being very careful with how we are allocating that product and getting the best fit for the next 12 months and forward.
Daniel O’Toole
Tash?
Tasha Jones
Okay. So, this next one comes from Ryan, who's been with us since the DroneDek days. What do you feel has been the biggest challenge with running a new publicly traded company in front of such a broad audience with the ability to say whatever they want, whenever they want? And what's been the biggest advantage?
Daniel O’Toole
You know, I would say no challenge, Ryan, just opportunity. Thanks for asking, and thanks for being with us since the beginning. Now I don't forget the OG guys, Brian Grigsby, [ Jeff Kong ], others. Appreciate everybody that's out there listening today. We know that you care.
You know, just opportunity. No two days are the same, every day is an exciting new day. You come in, and then Piyush mentioned the energy in the office. Every day I come in here, it's palpable. You can see high morale. You can see a dizzying evolution of projects. People are prideful. Everyone's trying to outmaneuver the next guy with great ideas and pride and be able to show off. You know, we have a normal showcase of sharing what's happening here, and we all rally and share that every day.
I'd be a hypocrite if I said anything was a negative. While there's things that aren't great sometimes, you gotta take the bad with the good. This is everything that I signed up for. It's better than I could have ever imagined.
I know our share price is down, and I'm not diminishing that. But what I'm saying is, I've come up with a mantra, what goes down must go up. It's anti-gravity, and that's what we're doing here at Arrive AI. I welcome questions not just on these earnings calls, but everybody knows how to reach me, and I want to be there for you guys. So thank you for that question, Ryan.
Tasha Jones
Okay. And this next one is -- we received a question about brand awareness, specifically how we're approaching marketing, given that many investors say they don't hear Arrive AI's name come up in their industries.
Daniel O’Toole
Mark, you want to take that one?
Mark Hamm
Yes. So just as we go through phases on developing our product and our supply chain, there are natural phases to how we develop our capabilities to go to market, and along with that, our brand. While it took a lot of attention and evangelizing the future of drone and robotic delivery to get here and to get funded and to put these resources and team in place, I think everybody's well aware of all the efforts, from Walmart and Zipline and just everybody out there, DoorDash. So that's no longer in question.
What we're focused on now is kind of that rifle shot approach to enterprise accounts and partners that are really the early innovators, the strategic investors in infrastructure like ours and what does it mean to market to them account by account. So you probably don't run into a lot of advertising for GE or Rolls-Royce aircraft engines in your life because you're not the purchaser of those things. We're looking for those equivalents in our industry that need to understand the awareness, the trade-offs, the chain of custody advantages, the efficiency advantages that our network brings to their fleets and their communities and their campuses, and that's where our marketing is focused and our branding is focused on.
Daniel O’Toole
Thank you. Tash?
Tasha Jones
Yes. Finally, you guys have had some strong patent news internationally. What's next? Are you guys looking at Asia? This one is from Rohan.
Daniel O’Toole
I'll tee that over at John Ritchison, our Chief Legal Counsel and our patent attorney. John?
John Ritchison
Thanks, Dan. That's a great question. I appreciate that question from the standpoint, gives me a lead -- I'll lead into it to talk a little bit about our IP. I'm going to break it up into two parts.
First, let me speak to the U.S. IP. We currently have 10 approved patents or issued patents. We've got 4 more pending in the patent office. And with that, we believe we've got covered the initial IP that we need for a strong moat to keep us in a competitive position.
I think Piyush mentioned about the energy that he saw when he was there. I'd say it's more than energy. There's a lot of strength in our young engineers, the men and women that are out there have come up with a lot of great ideas. I don't know of any other -- I'm sure they're out there, but I don't know of any other company right off the top that's got their IP attorney right on-site with their engineers. That's one thing that we do, and we try to strongly take those ideas. Currently, we've got about 19 ideas that are in the hopper. Those are coming through at the rate as the engineers finish up their design and development. But again, that's the U.S.
Now let me turn to the second part, and that's the international. We haven't talked much about the international, but we've been very strong in getting our patents across the pond and working out there. The specific question was Asia. We've got -- to date, we've got 13 issued patents. Most of those are in Asia, with the exception, I think, of South African and Brazil patents. The rest of them are in Asia proper, India, Singapore, Australia, Japan. I could list them, but that takes too much time. That's exciting from a standpoint that Asia is an immediate place that we have decided to start working hard on, trying to look at how we can take these international patents and doing some licensing with local concerns.
The other part of international we don't talk about much -- and I don't want to get too technical, but that's Europe. Most of the people in this room know it, but I'm sure the people on the call don't. We just recently got approved with our first patent for the European Union. That opens up the entire European for us to go ahead and open up those additional countries. So along with the Asian efforts, we now have the strong results, and we'll start heading up into Europe with our international licensing opportunities. I'll turn it back to Dan.
Daniel O’Toole
John, another quick question. You would agree that we have a strong first position patent portfolio in this space, right?
John Ritchison
Yes. I don't have it memorized like Dan does, but we beat several strong companies, Amazon, UPS, FedEx, a few others. And with that, when I say beat, our patents got out and approved by the patent office before theirs did. So that put us in a first position.
But I'd also be less than honest with you if I didn't say that a first position is nice, but our first position also comes with a strong number of claims. So we've got a lot of components and features in there. I thought that they were pretty well complete. And then I met these 40 engineers that we've got on-site that are thinking totally out of the box, so we've got a lot more stuff coming down the pipe.
Daniel O’Toole
And one more patent that people don't think about us for, if you could just throw something up about this, our winch patent for a [ drone package ].
John Ritchison
Yes, we've got -- that was one of the things with our strategic purchase, we rolled in what we call around here, a winch patent, which is a different way to handle the product coming from the drones. It's unique, and it allows you to focus or drop that package in a much more organized and controlled method.
Daniel O’Toole
Yes, thanks a lot. Hey, I just want to say, appreciate everybody listening to the call, caring enough to want to know what we're up to from a bird's eye view here at Arrive AI. I just want to say that the trajectory is strong. We are on track with every deliverable that we mark and take note of, and we are right on pace with every aspect of this business. We're running on all cylinders. Things are amazing in regard of getting recognized in the marketplace.
And I want to thank everybody for joining the call today. Also, I want to give a shout-out to my son, Bryce O'Toole. He's listening from his investment banking internship in New York City right now. Go get them, Bryce. Thanks, everybody. Back to our operator.
Operator
Thank you. This concludes the conference. Thank you for your participation. You may now disconnect.











코멘트 (0)
$ 버튼을 클릭하고, 종목 코드를 입력한 후 주식, ETF 또는 기타 티커를 연결합니다.